Abiopharma

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0000950103-26-007026 <b>Size:</b> 374 KB

(30% Negative) SHARPLINK, INC. (SBET) Reports Q2 2026 Financial Results

(99% Neutral) SERVE ROBOTICS INC. /DE/ (SERV) Announces Business Combination

Turbo Energy Expands AI-Driven Energy Platform in Chile To Capture Growing Distributed Energy Opportunity

Jiuzi Holdings, Inc. Announces $210,000 Realized Gains from DCIP Investment and Approves $100,000 Share Repurchase Program, Validating Sustainable Digital Asset Investment Framework

Bragg Powers 711’s Sportsbook Expansion with Kambi Integration and Fuze™ Technology in Belgium

CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial

IFF Opens Vanilla Innovation Center in Madagascar

Navigator Gas Announces 2026 Annual Meeting

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001918704-26-012622 <b>Size:</b> 636 KB

General Announcement: Announcement in relation to the Guarantors share capital

Par Pacific Announces Private Placement of $500 Million of Senior Notes

Net Asset Value(s)

New Form SCHEDULE 13G/A - Lyell Immunopharma, Inc. <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001193125-26-216076 <b>Size:</b> 9 KB

General Announcement: Overseas Regulatory Announcement